The Motley Fool Discussion Boards

Previous Page

Stocks I / Immunomedics, Inc.


Subject:  borrowed post Date:  9/15/2000  10:59 PM
Author:  OnWis Number:  52 of 89

I saw this on the AMGN board:
Immunomedics . . . was forced to shut down clinical trials of an experimental cancer drug after a patient died, according to an analyst who spoke with the company.

Copyright 1996-2020 trademark and the "Fool" logo is a trademark of The Motley Fool, Inc. Contact Us